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Haemonchosis, caused by the abomasal nematode Haemonchus contortus, is a common parasitic disease of sheep. Our
previous results showed that a soluble fraction from adult stages of the nematode (p26/23) induced partial protection against
challenge. Recombinant DNA technology was applied to obtain a synthetic protein (rHcp26/23). Immunological assays (ELISA,
Western blotting, and immunolocalization), using sera from lambs immunized with p26/23, conﬁrmed the identity of the
recombinant protein and demonstrated that the synthetic protein is equivalent to the puriﬁed protein employed in the previous
immunoprophylaxis studies. Vaccination of lambs with 300μg of rHcp26/23 and Freund’s adjuvant elicited a notable speciﬁc
antibody response. Immunization did not induce any signiﬁcant protection after challenge with 16000 infective larvae of H.
contortus, and comparable values for parasite faecal egg output, packed cell volume, and abomasal parasite burdens were found in
vaccinated and control animals.
1.Introduction
Haemonchus contortus (Trichostrongylidae, Nematoda) is
the etiological agent of haemonchosis, a worldwide dis-
tributed parasitic disease aﬀecting small ruminants, partic-
ularly sheep and goats. Infections by this helminth cause
digestive disturbances such as inappetence, alterations of
energy and protein metabolism, and anemia accompanied,
in severe cases, by hypoproteinemia and oedema [1]. The
control of the disease has been based, almost exclusively,
on the use of anthelmintics. However, their massive and
indiscriminate use has led to the appearance of parasite
isolateswithanthelminticresistancetothemainantiparasitic
drug groups [2]. This situation has triggered eﬀorts towards
the exploration of potentially immunoprotective antigens.
Among the most promising are H11, H-gal-GP, some
excretory-secretory (ES) antigens, and the somatic antigen
p26/23 [3–8]. Results obtained in the diﬀerent vaccination
trialshavevaried,someofthemachievingnotableprotection
levels from 32.2–90% reductions in parasite egg shedding
and61–78%reductionsinwormpopulationsintheabomasa
of vaccinated lambs. Most investigational endeavours have
concentrated on parasite antigens not detected by infected
hosts, the so-called “hidden antigens” (HAGs) normally
present in the parasite’s gut [9, 10]. This approach has
been successfully used to vaccinate against cattle ticks with
Bm86 [11]. In spite of the potential advantages of this
approach [12], the protection levels achieved with HAGs
are dependent on the revaccination of animals; therefore
labour costs and management methods of small ruminants
render this approach less convenient. Conversely, exposed
antigens (“natural antigens”, NAGs), although subjected
to natural selection, could be used in the absence of re-
vaccination because exposure to the parasite would act2 Veterinary Medicine International
as a natural booster for hosts. Our group has already
demonstrated that a protein fraction obtained from adult
worms, p26/23, was immunoprotective in 3.5–5-month-old
lambs challenged with H. contortus [4, 13]. Recently, the
content of this fraction has been analyzed, and the major
protein present has been puriﬁed, immunolocalized, and
partially sequenced [14]. In the present paper we present
the cloning and expression of the recombinant protein,
rHcp26/23. In addition, a pilot immunization experiment
against H. contortus challenge has been carried out.
2.MaterialandMethods
2.1. Helminths. Adult H. contortus were recovered from the
abomasa of monospeciﬁcally infected lambs 2-3 months of
age with 12000 third stage larvae (L3) of a parasite isolate
originally obtained from Merck, Sharp & Dohme, Spain in
1987 and maintained in our facilities by serial passage in
donor lambs. Animals were fed with commercial pelleted
food (Superfeed), hay, and water ad libitum. Forty-two days
after infection, lambs were slaughtered, and adult helminths
were recovered from the abomasal content and mucosa.
Helminths were extensively washed with 150mM PBS (pH
7.4) containing protease inhibitors, 1mM phenyl metasul-
fonile ﬂuoride (Fluka), and Ethylenediamine tetraacetic acid
(EDTA)(Sigma)at4◦C.Helminthswerepreservedat −80
◦C
until used. L3 were obtained by fecal culture (26
◦C, 10 days,
and >80% relative humidity), baermannization, and partial
puriﬁcation on ﬁlter paper. Recovered larvae were washed
with PBS and preserved at 4◦C for infection purposes or at
−80
◦C for biochemical and immunological studies.
2.2. Puriﬁcation of p26/23 from H. contortus. Adult worms,
largely females, were subjected to freezing and thawing cycles
(−20
◦C, room temperature), homogenized, and centrifuged
at 30000×g, 4◦C for 30min to obtain the supernatant
(AdultSoluble Extract,ASE). Puriﬁcation of p26/23 involved
the sequential use of aﬃnity chromatography with S-Hexyl
Glutathione and reverse-phase chromatography (Vydac
214TP5415 column) [14, 15]. Proteins were analyzed by 15%
polyacrylamide gel electrophoresis with 1% sodium dodecyl
sulphate (Merck) and 5% mercaptoethanol (Merck) (SDS-
PAGE). Proteins were electrotransferred to nylon mem-
branes (Immobilon P, Millipore). Pooled sera from lambs
immunized with the fraction p26/23 [13] were used in the
Western blotting (WB) to identify the protein. Membrane
strips containing p26/23 were excised, the protein was eluted
[16], and N-terminal sequence was determined (Centro
de Investigaciones Biol´ ogicas, CIB, CSIC, Madrid). Larval
soluble extract (LSE), for SDS-PAGE and WB, was obtained
in the same manner as ASE. Protein concentration was
determinedbyamodiﬁedBradfordmethod(BioRadprotein
assay).
2.3. Sera. Rabbit hyperimmune sera against puriﬁed p26/23
were obtained from 2 New Zealand X California Giant
rabbits, 2 months of age. Animals received 3 intramuscular
doses of 20μg each of the protein, at 14-day intervals. First
injection was administered with Freund Complete Adjuvant
(Sigma) and the next two with Freund Incomplete Adjuvant
(Sigma). To obtain antisera against the recombinant protein
a similar protocol was used, although 100μg were used on
eachinjection. Serafromlambsimmunized withthe fraction
containing native p26/23 came from a previous experiment
[4, 13].
2.4. Nucleic Acid Extraction and Ampliﬁcation of p26/23
Coding Sequence. Adult H. contortus (10–15) were homog-
enized in 1mL TRIzol (Gibco BRL) [17]. Recovered RNA
in the aqueous phase was precipitated with 0.5mL iso-
propanol for 10min at room temperature and centrifuged
at 12000×g (10min, 4◦C). Precipitate was washed with
ethanol for 5min at 7500×ga n d4 ◦C and resuspended
in RNAse-free water. Extract was subjected to treatment
with DNAse (Dnase I Rnase-free, Roche) [18]. RT-PCR
was carried out in two independent steps: synthesis of
cDNA (1st Strand cDNA Synthesis Kit, AMV, Roche) using
hexanucleotide random primers in 40μLﬁ n a lv o l u m ea n d
ampliﬁcation by PCR following the procedures described
below. The partial N-terminal amino acid sequence of the
protein p26/23 puriﬁed from adult H. contortus [14] showed
85% identity with the hypothetical protein HCC00515
from H. contortus (NEMBASE), deduced on the nucleotide
sequence from a cDNA library. Therefore, the available
N-terminus sequence of this protein and the nucleotide
sequence of HCC00515 were used as template to design
two primers with BamHI and HindIII restriction targets:
FBamHI(5  GGATCCGCAGGACTGTTCGCACAT 3 )and
RHindIII (5  AAGCTTTCAGTCTTTCGCGGACTTG 3 ).
Reaction mixture included 1μL cDNA, 0.2mM of each
of deoxynucleoside triphosphates (dATP, dCTP, dGTP, and
dTTP) (Roche), 50mM KCl, 2.5mM MgCl2,3n g / μLo fe a c h
primer, 5IU of Taq DNA polymerase (Roche), and 10mM
Tris HCl, pH 8.3, in a ﬁnal volume of 50μL. The PCR
ampliﬁcation included denaturalization for 3min at 94
◦C,
followed by 30 cycles (95
◦C, 1min) with one annealing-
elongation step at 71
◦C for 1min and, ﬁnally, an elongation
step at 72
◦C for 10min. PCR was carried out in a PTC-
100 (MJ Research Inc.). The resulting fragment was cloned
in the vector pGEM-T (Promega), and the construct was
used to transform Escherichia coli XL2-blue [18]. Positive
bacterial colonies were identiﬁed by PCR (94
◦C, 1min;
54
◦C, 1min; 72
◦C, 1min), followed by 7min, 72
◦Ct r e a t -
ment, employing the primers SP6 (5  ATTTAGGTGACA-
CTATAGAA 3 )a n dT 7( 5   TAATACGACTCACTATAG-
GG 3 ).minipreps were prepared with PCR positive colonies
(QIAprep Spinminiprep kit (250) (Qiagen)).
2.5. Expression and Puriﬁcation of Recombinant p26/23
(rHcp26723). The insert was cloned in the expression vector
pQE30 (QIAexpress vector, Qiagen), and the construct was
employed to transform E. coli M15 (PREP 4) (Qiagen). Posi-
tive bacterial colonies were identiﬁed by PCR employing the
primers FpQE (5  GAATTCATTAAAGAGGAGAAA 3 ),
for the plasmid and R (5  TCAGTCTTTCGCGGACTT-
G3  ), for the insert. The nucleotide sequence of PCRVeterinary Medicine International 3
products and the positive bacterial clones in E. coli XL2-
blue and M15 were determined by the Department of
Genetics (Faculty of Veterinary Science, UCM, Madrid).
The expression of the recombinant protein (rHcp26/23) was
carried out with a PCR positive clone of E. coli cultured
in LB broth medium with 100μg/mL ampicillin (Roche)
and 25μg/mL kanamycin (Sigma) at 37
◦C. Cultures were
induced with 0.02–2mM isopropyl-β-thiogalactopyranoside
(IPTG) (Roche) treatment. Cell pellets from cultures were
resuspended, and protein was solubilized in both denaturing
and nondenaturing conditions. In the puriﬁcation under
denaturing conditions, pellets were incubated in lysis buﬀer
with 8mM urea centrifuged, and supernatants, recovered.
The process was repeated four times. The recombinant
His6tagged p26/23 was puriﬁed in 10 × 1cm columns (Bio
Rad) of Ni-NTA agarose (Qiagen). Solubilization under
nondenaturing conditions was carried out by resuspending
cell pellets in a buﬀer with 20mM imidazole at pH 8.0.
Cells were disrupted by sonication, and the puriﬁcation
of the recombinant protein was carried out with the
same column as above and eluted with 250mM imidazole.
Proteins obtained from both puriﬁcation methods were
dialyzed against PBS and lyophilized until use. Recom-
binant proteins were analyzed by SDS-PAGE and WB
using pooled sera from vaccinated lambs with the fraction
p26/23.
2.6. Immunolocalization of p26/23 in H. contortus.
Immunolocalization of p26/23 in adult H. contortus
was carried out following the methods described in [14].
Sections were washed with PBS, blocked with 5% foetal
bovine serum (Sigma) in PBS for 1 h at room temperature,
and incubated with rabbit anti-p26/23 and pooled anti-
rHcp26/23sera(1:1000inPBS).Theslidesweremountedin
Crystal/ Mount aqueous-dry mounting medium (Biomeda)
and examined under an Olympus BX-60 ﬂuorescence
microscope.
2.7. Lambs Vaccination with Fraction p26/23
2.7.1. Lambs and Experimental Design. Twenty-four, 3-
month old female helminth-free lambs (Manchego breed)
were obtained from a local producer (Toledo). Animals
were kept at isolation stables from our facilities, clinically
monitored along the experiment, and the conditions were
approved by the Madrid Veterinary Faculty Committee
for Animal Experimentation. Lambs were distributed in a
stratiﬁed manner (live weight) onto 5 experimental groups.
Group 1 animals (no. 1, 2, 3, 4, and 5) were immunized
with rHcp26/23 puriﬁed under nondenaturing conditions;
G r o u p2a n i m a l s( n o .6 ,7 ,8 ,9 ,a n d1 0 )r e c e i v e dd e n a t u r e d
rHcp26/23; Group 3 animals (no. 11, 12, 13, 14, and 15)
received only adjuvant; Group 4 animals (no. 16, 17, 18, 19,
and 20) were the unvaccinated, challenged control, Group
5 animals (no. 21, 22, 23, and 24) were the unvaccinated
and unchallenged negative control. Lambs from Groups 1
and 2 received immunizing injections (intramuscular and
subcutaneous in the groin and hind legs) on days 0, 14,
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Figure 1: SDS-polyacrylamide gel of Coomassie blue stained
fractions during puriﬁcation under nondenaturing conditions of
rHcp26/23. Lane 1: MW markers in kDa; 2: uninduced E. coli
culture; 3: induced E. coli culture; 4: starting sample; 5: unbound
f r a c t i o n ;6 :e l u a t ew i t hb u ﬀer I (without imidazole); 7: eluate with
20mM imidazole; 8: eluate with 250mM imidazole.(∗) puriﬁed
rHcp26/23.
and 28. The ﬁrst injection (100μg recombinant protein)
was administered in 1mL Freund’s Complete Adjuvant;
the second and third injections were administered in 1mL
Freund’sIncompleteAdjuvant.Onthesamedayslambsfrom
Group 3 received only adjuvant. On day 42, animals from
Groups 1–4 were challenged with 16000L3 of H. contortus by
means of bucoesophagic catheter.
2.7.2. Blood Sampling, Parasitological, Biopathological, and
Immunological Determinations. Coproscopical analyses were
carried with a modiﬁed McMaster technique [19]. Along
the experiment blood samples were obtained by jugular
venipuncture in evacuated tubes (Vacutainer) every 14
days. Packed cell volume (PCV) and haemoglobin con-
centration were determined with standard laboratory tech-
niques. Serum-speciﬁc antibody response was determined
by ELISA and Western blot. In the ELISA, microplate wells
(Nunc) were coated with 5μg/mL (ASE, LSE) or 1μg/mL
(rHcp26/23). Individual lambs’ sera were diluted 1:400 in
PBS, and second antibody was alkaline phosphatase-labelled
anti-sheep IgG (Sigma) 1:30000 diluted. Absorbance was
read at 405nm. Western blots were carried out with ovine
(1/100 dilution) or rabbit sera (1/1000 dilution) for 2h at
37
◦C. Secondary antibody was peroxidase-labelled mouse
monoclonal (clone GT-34) anti-sheep IgG (Sigma) and
employed at 1/1000 dilution for 1h, 37
◦C. Peripheral
lymphocyte response was determined following previously
described techniques with slight modiﬁcations [13, 20].
Brieﬂy, blood samples in 1% heparin (Rovi) obtained from
the experimental animals were diluted (1:1) in RPMI
1640 medium (Bio-Whitakker). The lymphocyte enriched
fraction was obtained from the interface, after centrifugation
(800×g) for 25min, of 4mL Ficoll-Paque Plus (Amersham
Biosciences) with diluted blood on it. Viable cells (2.5×104)
were resuspended in RPMI supplemented with 10% foetal
bovine serum (Sigma) and 1% penicillin-streptomycin mix-
ture (Bio-Whittaker). Antigens were employed at 5μg/mL4 Veterinary Medicine International
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Figure 2: Western blots of adult (ASE) (a) and third-stage larvae (LSE) (b) soluble extracts of H. contortus and rHcp26/23 (c). Proteins were
subjected to SDS-PAGE, transferred to nylon membranes, and probed with rabbit hyperimmune sera against native p26/23 (Lanes 1) and
rHcp26/23 (Lanes 2), pooled sera from lambs vaccinated with p26/23 (Lane 3), and negative sheep serum (Lane 4). MW: Molecular weight
markers in kDa.
(a) (b) (c)
Figure 3: Immunolocalization of p26/23 in histological sections of adult H. contortus. Fluorescence was detected with antinative p26/23
hyperimmune rabbit serum and an anti-rHcp26/23 hyperimmune rabbit serum. Antirabbit Cy3-conjugated was the secondary antibody.
Sections of adult H. contortus showed p26/23 recognition in the hypodermic chords of the nematode with anti-p26/23 (a) and anti-
rHcp26/23 (b). Section incubated with normal rabbit serum (c).
(ASE) or 1μg/mL (rHcp26/23). Cultures were kept for 5 days
at 37
◦C in a 95% air/5% CO2 atmosphere. Concanavalin
(Amersham) was used as positive internal control (3 days at
2.5μg/mL). Cultures were pulsed with 2μCi/mL of methyl-
H3 thymidine (Amersham) 18 hours before harvest. Results
were expressed as stimulation indexes (SI) [mean counts
permin (cpm) of the triplicate stimulated cultures/mean
cpm of the triplicate nonstimulated cultures]. On day 42
post challenge, animals were slaughtered at a local abattoir
(Getafe, Madrid), abomasa removed, and taken to the
laboratory under refrigeration. Individual abomasa were
opened and the adult helminths in the content and the
mucosa subsequently washed in cold PBS. A 10% aliquot
of total recovered helminths was ﬁxed in 5% buﬀered
formalin and the worms present, counted (males, females).
To determine the parasite dry weight 40 male and 40 female
H. contortus were weighed, kept at 100
◦C, until they reached
a constant weight. Parasite length was measured in 40 male
and female helminths employing a transilluminator and
curvimeter [21].Veterinary Medicine International 5
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Figure 4: Serum-speciﬁc IgG response, determined by ELISA, of
lambs along immunization with rHcp26/23 and challenge with
16000 third-stage larvae of H. contortus, against rHcp26/23 (a) and
adult soluble extract of the parasite (ASE). G1 (): lambs (n =
5) immunized with 3 doses (100μg each) of recombinant p26/23
(rHcp26/23) puriﬁed under nondenaturing conditions and chal-
lenged; G2 (): lambs vaccinated with 3 doses of rHcp26/23 puri-
ﬁed under denaturing conditions and challenged; G3 (): lambs
receiving adjuvant injections and challenged; G4 ( ): unvaccinated
andchallenged lambs. Arrow:day ofexperimental challenge. Values
are means ± standard deviation of three determinations.
2.8. Statistical Analysis. To normalize variance worm bur-
dens were log(x + 1) transformed, and a nonparametric test
(two-tailed Mann-Whitney) was employed to calculate the
statisticallysigniﬁcantdiﬀerences.Averagecomparisonswere
carried out to estimate the eﬀect of vaccination on diﬀerent
days (IgG, faecal egg output) with a two-tailed Student t test.
The level of signiﬁcance was established at P<. 01.
3. Results
3.1. Expression and Puriﬁcation of rHcp26/23. The optimal
overexpression of rHcp26/23 in the pQE30/E. coli M15
system was achieved after induction of bacterial cultures
with 0.02mM IPTG for 2h (not shown). Electrophoretic
analysis of supernatants and sediments obtained from the
cultures of transformed E. coli showed that most of the
protein was solubilized in the ﬁrst washing with 8M urea.
Aﬃnity chromatography allowed the puriﬁcation of the
recombinant protein between pH 5.9 and 4.5. Similarly,
extraction under nondenaturing conditions rendered, after
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Figure 5: Peripheral lymphoproliferative response of lambs along
the experimental immunization and challenge with 16000 third
stage larvae of H. contortus in the presence of 1μg/mL recombinant
protein (rHcp26/23) (a) and 5μg/mL adult soluble extract (ASE)
of the helminth (b). SI: Stimulation index. Arrow: day of challenge.
Values are the means ± standard deviation of three determinations.
G1: solid bars; G2: grey bars; G3: stripped bars; G4: white bars; G5:
woven bars.
aﬃnity chromatography, a single band, as assessed by SDS-
PAGE (Figure 1,l a n e8 ) .
3.2. Cross-Reactivity between the Native (P26/23) and
the Recombinant Protein (rHcp26/23). WB analysis of
rHcp26/23, and soluble extracts from both infective larvae
(LSE) and adult stages (ASE) of H. contortus with sera
from rabbit antinative p26/23, rabbit anti-rHcp26/23, and
lamb anti-p26/23 fraction, showed comparable reactivity
patterns irrespective of the antigen source (LSE, ASE). A
clear band, ca. 24–26kDa, was developed in both stages of
the helminth, using the serum against the native p26/23
(Figures 2(a) and 2(b), lane 1) or the anti-rHcp26/23
(Figures 2(a) and 2(b), lane 2). It was also observed that
the recombinant protein was recognized by the sera from
vaccinated lambs (p26/23) (Figure 2(c),l a n e3 ) .S o m e
reactivity was found at ca. 46kDa, particularly when ASE
(Figure 2(a)) and rHcp26/23 (Figure 2(c))w e r ep r o b e d
with immune sera. Antigenic similarity between p26/23 and
rHcp26/23 was conﬁrmed by immunolocalization studies.6 Veterinary Medicine International
Table 1: Number of adult Haemonchus contortus (females, males, total helminths) and recovery rate (as percentage of infective dose
administered) recovered from the abomasa of challenged lambs at the end of the experiment. Helminth counts were log(x+1) transformed.
Numbers within brackets represent the parasite biomass (mg) determined. Data are average ± standard deviation.
Group Nr. Animal Females Males Adults % Recovery
G1
1 3.17 3.01 3.4 15.81
2 2.97 2.8 3.201 9.93
3 1.78 1.32 1.9 0.5
4 3.25 3.28 3.57 23.43
5 3.2 3.26 3.53 21.56
3.07 ± 2.83 .03 ±2.93 .35 ± 3.21 4 .25 ±9.3
(252.7 ±145) (124.37 ±86) ((377.07 ±253.88)
G2
6 1.85 1.7 2.08 0.75
7 2.84 2.23 2.94 5.43
8 3.19 3.13 3.46 18.18
9 2.04 1.7 2.2 1
10 3.71 3.66 3.98 61.06
3.18 ± 3.33 .09 ±3.28 3.44 ±3.61 17.28 ±25.47
(377 ±481.64) (100.65 ±121.3) (496.43 ±596)
G3
11 2.51 2.17 2.68 3
12 2.91 2.79 3.15 9
13 2.66 2.5 2.89 4.87
14 2.54 2.14 2.69 3.06
15 3.193 3.13 3.46 18.25
2.84 ±2.71 2.71 ±2.70 3.08 ±3.01 7.63 ±6.41
(191.95 ± 127.0) (53.95 ±48.99) (245.9 ±168.5)
G4
16 3.32 3.28 3.6 25.25
17 2.99 2.91 3.25 11.31
18 2.55 2.39 2.78 3.81
20 3.12 2.919 3.33 13.5
2.98 ±2.92 2.88 ±2.86 3.23 ±3.19 10.77 ±9.77
(208.31 ± 124.9) (83.21 ±38.49) (291.62 ±146)
Both hyperimmune sera (anti-p26/23 and anti-rHcp26/23),
but not the serum from nonimmunized rabbit, speciﬁcally
reacted against the hypodermic chords of adult H. contortus
sections (Figure 3).
3.3. Immunization Trial. Immunization with the recombi-
nant protein elicited a strong speciﬁc IgG systemic response
against the recombinant protein after the ﬁrst immunizing
injection (Figure 4(a)). Interestingly, immunized animals
with the recombinant protein also displayed a strong
response in ELISA against ASE of H. contortus (Figure 4(b)).
Comparable results were observed in the Western blots
with individual lambs’ sera from the patent period of the
infection (not shown). Similarly, immunization induced
signiﬁcantly higher lymphoproliferative response of lambs
after challenge against the recombinant protein (Figure 5(a))
and soluble extracts of H. contortus (Figure 5(b))a n dl a r v a l
extracts of the helminth (not shown). Immunized lambs
(G1 and G2) showed a slight shortening of the duration of
prepatentperiod(18days)whencomparedtononvaccinated
and challenged animals (G3 and G4). However, average
data of parasite eggs faecal shedding from immunized
0
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123456
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Figure 6:Averagefaecaleggoutputofexperimentallambs(eggsper
gram (epg)) along the challenge infection with 16000 third stage
larvae of H. contortus administered by buco-oesophagic catheter.
Symbols as in Figure 4.
animals were higher than those found in the control groups
(Figure 6). These diﬀerences were not signiﬁcant given the
high variation found within each experimental group. AllVeterinary Medicine International 7
challenged animals displayed a transient fall of both PCV
and haemoglobin concentration (not shown), during the
prepatent infection and without diﬀerences among groups.
Adult helminths were recovered from all challenged animals
at necropsy (Table 1). The recovery rate (%) of the infective
dose administered was low and no evidence of protection
aﬀorded by immunization with rHcp26/23 puriﬁed under
nondenaturing (Group 1) or denaturing (Group 2) condi-
tions was obtained (P>. 5).
4. Discussion
A number of potentially protective HAGSs of H. contortus
have been cloned and expressed, among them H11 and H-
gal-GP [7, 10] .F e wa t t e m p t sh a v eb e e nm a d et oc l o n eN A G S
fromthishelminthspecies,exceptfortheexpressionofsecre-
tory/excretory proteins, particularly ES24 [22]. The present
paper describes the cloning and prokaryotic expression (E.
coli) of the H. contortus somatic antigen p26/23, a protein
showing a notable immunoprophylactic value against lamb
haemonchosis [4, 13]. The protocol used for the cloning
and expression was very eﬃcient, and puriﬁed histidine-
tagged rHcp26/23 was obtained both in nondenaturing and
denaturing conditions. The approximate MW of rHcp26/23
has a comparable value (23.16kDa) to that reported for the
nativeprotein(24kDa)[14].Nodiﬀerenceswereobservedin
electrophoretic motility between the protein puriﬁed under
denaturing and nondenaturing conditions. The expressed
protein (rHcp26/23) was recognised in WB by sera from
vaccinated lambs with p26/23 [4] and also by rabbit anti-
p26/23 hyperimmune serum. Moreover, sera raised against
the recombinant protein showed a similar recognition of
the puriﬁed native protein. These results suggest that the
recombinant protein corresponds to the native peptide
present in the immunoprotective fraction described by these
authors. In the WB, rabbit and lamb immune sera revealed
the expected MW (ca. 23-24kDa), and aminor recognition
was seen around 46kDa. A comparable ﬁnding was obtained
in our previous work with the protective fraction [4]a n d
the puriﬁed native protein [14]. Given the puriﬁcation
m e t h o d( e l u t i o nf r o mm e m b r a n e - b o u n dp r o t e i n s )n op o s -
sible contaminants of twofold MW could be present. These
results suggest that p26/23 might spontaneously dimerize
thus displaying two reactive bands in WB. The immune
recognition pattern found in nematode sections constitutes
an additional evidence of the similarity of the native protein
and rHcp26/23. In addition, it reinforces the conclusion that
p26/23 is not related to ES24 since the latter is produced
in the oesophagus and excreted/secreted during H. contortus
feeding [22].
In spite of the strong immune response (IgG and
lymphoproliferative response) elicited by the immunization
of lambs with the recombinant protein (rHcp26/23) no
protection against the H. contortus challenge was found.
Actually no signiﬁcant diﬀerences were found in helminth
burdens in abomasum at the end of the experiment. In
addition, no immunization-related variations were found in
the epg and biopathological parameters determined (PCV,
Hb). The results with the recombinant protein sharply
contrast with those obtained with the fraction containing
p26/23 [4] where vaccination of younger than 5-month-
old lambs elicited a reduction over 60% in abomasal worm
burdens and epg counts.
Our results are in line with those obtained in most
vaccination trials against haemonchosis with recombinant
antigens (H11, H-gal-GP, and ES) whereas the native coun-
terparts were able to induce signiﬁcant levels of protection
against challenge [7, 23]. A number of reasons have been
invoked; among them the inadequate renaturalization of the
recombinant proteins and glycosylation of the protective
antigens [24–26]. The protein expressed, p26/23, apparently
is not glycosylated [27]. Present experiment was carried out
withaverysimilardesigntothatusedwiththenativefraction
with a signiﬁcant protective eﬀect [4]. Moreover, the results
obtained in ELISA and lymphocyte proliferation tests rule
out the inadequacy of the immunizing protocol followed. It
has been suggested that recombinant expression could be an
inadequate strategy to helminth vaccination. However, some
encouraging results have been obtained with recombinant
galectin in adult goats [28]. In many vaccination trials with
unsuccessful results it is not known whether the native
parasite antigen itself could induce protection or the relative
importance of its epitopes [29]. In our case the native p26/23
elicitedsigniﬁcantprotectioninsimilarconditions[4].Given
the economic importance of haemonchosis, further research
is needed. In particular, the protein should be expressed
in eukaryotic systems, critical epitopes determined, and
alternative immunization strategies explored.
Acknowledgments
Leticia Garc´ ıa-Coiradas had a predoctoral fellowship from
the Spanishministry of Education and Science (MEC). Fran-
cisco Angulo-Cubill´ an had a predoctoral fellowship from
Venezuelan government. Sequencing of PCR products and
bacterial clones was kindly performed by the Department
of Genetics, Faculty of Veterinary Science, Madrid. Advice
by Dr. Bin Zhan (George Washington University) on the
immunolocalization studies is acknowledged. Critical read-
ingbyDr.S.M´ endez(J.A.BakerInstitute,CornellUniversity,
USA) and comments from Dr. A. Tora˜ no (Instituto de
Salud Carlos III, Madrid) greatly improved the paper. The
research was funded partially by Project AGL2000-0781 and
AGL2006-10589 (CICYT, MICINN).
References
[1] P. H. Holmes, “Pathophysiology of nematode infections,”
International Journal for Parasitology, vol. 17, no. 2, pp. 443–
451, 1987.
[2] F. Jackson and R. L. Coop, “The development of anthelmintic
resistanceinsheepnematodes,”Parasitology,vol.120,pp.S95–
S107, 2000.
[3] N. Bakker, L. Vervelde, K. Kanobana et al., “Vaccination
against the nematode Haemonchus contortus with a thiol-
binding fraction from the excretory/secretory products (ES),”
Vaccine, vol. 22, no. 5-6, pp. 618–628, 2004.8 Veterinary Medicine International
[ 4 ]I .A .D o m ´ ınguez-Tora˜ no, M. Cuquerella, MA. T. G´ omez-
Mu˜ noz, S. M´ endez, F. J. Fern´ andez-P´ erez, and J. M. Alunda,
“Vaccination of Manchego lambs against Haemonchus con-
tortus with a somatic fraction (p26/23) of adult parasites,”
Parasite Immunology, vol. 22, no. 3, pp. 131–138, 2000.
[5] E. A. Munn, T. S. Smith, M. Graham, C. A. Greenwood, A.
S. Tavernor, and G. Coetzee, “Vaccination of merino lambs
against haemonchosis with membrane-associated proteins
from the adult parasite,” Parasitology, vol. 106, no. 1, pp. 63–
66, 1993.
[6] E. A. Munn, T. S. Smith, M. Graham, A. S. Tavernor, and C.
A .G r e e n w o o d ,“ T h ep o t e n t i a lv a l u eo fi n t e g r a lm e m b r a n e
proteins in the vaccination of lambs against Haemonchus
contortus,” International Journal for Parasitology, vol. 23, no.
2, pp. 261–269, 1993.
[7] W. D. Smith and D. S. Zarlenga, “Developments and hurdles
in generating vaccines for controlling helminth parasites of
grazingruminants,”VeterinaryParasitology,vol.139,no.4,pp.
347–359, 2006.
[ 8 ]H .D .F .H .S c h a l l i ga n dM .A .W .V a nL e e u w e n ,“ P r o t e c t i v e
immunitytotheblood-feedingnematodeHaemonchuscontor-
tus induced by vaccination with parasite low molecular weight
antigens,” Parasitology, vol. 114, no. 3, pp. 293–299, 1997.
[9] D. P. Jasmer and T. C. McGuire, “Protective immunity to a
blood-feeding nematode (Haemonchus contortus) induced by
parasite gut antigens,” Infection and Immunity, vol. 59, no. 12,
pp. 4412–4417, 1991.
[10] D. P. Knox, D. L. Redmond, G. F. Newlands, P. J. Skuce, D.
Pettit, and W. D. Smith, “The nature and prospects for gut
membrane proteins as vaccine candidates for Haemonchus
contortus and other ruminant trichostrongyloids,” Interna-
tional Journal for Parasitology, vol. 33, no. 11, pp. 1129–1137,
2003.
[11] P. Willadsen, G. A. Riding, R. V. McKenna et al., “Immuno-
logic control of a parasitic arthropod. Identiﬁcation of a
protective antigen from Boophilus microplus,” Journal of
Immunology, vol. 143, no. 4, pp. 1346–1351, 1989.
[12] E. A. Munn, “Rational design of nematode vaccines: hidden
antigens,” International Journal for Parasitology, vol. 27, no. 4,
pp. 359–366, 1997.
[13] I. A. Dom´ ınguez-Tora˜ n o ,F .J .F e r n´ andez-P´ erez, M. T. G´ omez-
Mu˜ noz, J. M. Alunda, and M. Cuquerella, “Humoral and
cellular response in lambs vaccinated against Haemonchus
contortus with p26/23,” Small Ruminant Research, vol. 50, no.
1-2, pp. 29–37, 2003.
[14] L. Garc´ ıa-Coiradas, F. Angulo-Cubill´ an, S. M´ endez et al.,
“Isolation and immunolocalization of a putative protective
antigen(p26/23)fromadultHaemonchuscontortus,” Parasitol-
ogy Research, vol. 104, no. 2, pp. 363–369, 2009.
[15] D. Carr, The Handbook of Analysis and Puriﬁcation of Peptides
andProteinsbyReverse-PhaseHPLC,GraceVydac,3rdedition,
2002.
[16] B. Szewczyk and D. F. Summers, “Eﬃcient elution of
puriﬁed proteins from polyvinylidene diﬂuoride membranes
(Immobilon) after transfer from SDS-PAGE and their use as
immunogens,” in Methods in Molecular Biology,M .M a n s o n ,
Ed., pp. 7–12, The Humana Press, Totowa, NJ, USA, 1992.
[17] P. Chomczynski and N. Sacchi, “Single-step method of
RNA isolation by acid guanidinium thiocyanate-phenol-
chloroform extraction,” Analytical Biochemistry, vol. 162, no.
1, pp. 156–159, 1987.
[18] J. Sambrook, E. F. Fritsch, and T. Maniatis, Molecular Cloning:
A Laboratory Manual, Cold Spring Harbor Laboratory Press,
New York, NY, USA, 2nd edition, 1989.
[19] MAFF (Ministry of Agriculture, Fisheries and Food, “Manual
of Veterinary Parasitological Laboratory Techniques,” HMSO,
London, 1971.
[20] J.M.Alunda,F.Angulo-Cubill´ an,andM.Cuquerella,“Immu-
nizationagainstovinehaemonchosiswiththreelowmolecular
weight somatic antigens of adult Haemonchus contortus,”
Journal of Veterinary Medicine B, vol. 50, no. 2, pp. 70–74,
2003.
[21] W. J. Coadwell and P. F. Ward, “Observations on the develop-
ment of Haemonchus contortus in young sheep given a single
infection,” Parasitology, vol. 71, no. 3, pp. 505–515, 1975.
[22] H. D. F. H. Schallig, M. A. W. Van Leeuwen, B. E. Verstrepen,
and A. W. C. A. Cornelissen, “Molecular characterization
and expression of two putative protective excretory secretory
proteins of Haemonchus contortus,” Molecular and Biochemical
Parasitology, vol. 88, no. 1-2, pp. 203–213, 1997.
[23] S. E. Newton and E. N. T. Meeusen, “Progress and new
technologies for developing vaccines against gastrointestinal
nematodeparasitesofsheep,”ParasiteImmunology,vol.25,no.
5, pp. 283–296, 2003.
[24] D. P. Knox, D. L. Redmond, P. J. Skuce, and G. F. J. Newlands,
“The contribution of molecular biology to the development
of vaccines against nematode and trematode parasites of
domesticruminants,”VeterinaryParasitology,vol.101,no.3-4,
pp. 311–335, 2001.
[ 2 5 ]E .C l a e r e b o u t ,D .P .K n o x ,a n dJ .V e r c r u y s s e ,“ C u r r e n t
research and future prospects in the development of vaccines
against gastrointestinal nematodes in cattle,” Expert Review of
Vaccines, vol. 2, no. 1, pp. 147–157, 2003.
[26] J. P. Dalton, P. J. Brindley, D. P. Knox et al., “Helminth
vaccines: from mining genomic information for vaccine
targets to systems used for protein expression,” International
Journal for Parasitology, vol. 33, no. 5-6, pp. 621–640, 2003.
[27] M. T. Gomez-Mu˜ noz, M. Cuquerella, and J. M. Alunda,
“Identiﬁcation and partial puriﬁcation of a 26 kilodalton
antigen of adult Haemonchus contortus,” International Journal
for Parasitology, vol. 26, no. 3, pp. 311–318, 1996.
[28] S. Yanming, Y. Ruofeng, C. I. Muleke, Z. Guangwei, X.
Lixin, and L. Xiangrui, “Vaccination of goats with recom-
binant galectin antigen induces partial protection against
Haemonchus contortus infection,” Parasite Immunology, vol.
29, no. 6, pp. 319–326, 2007.
[29] P. Geldhof, V. De Maere, J. Vercruysse, and E. Claerebout,
“Recombinant expression systems: the obstacle to helminth
vaccines?” Trends in Parasitology, vol. 23, no. 11, pp. 527–532,
2007.